Basics Tandem Diabetes Care, Inc. Tandem Diabetes Care Inc is a provider of medical care devices in the United States. Its products aid in the delivery of insulin and getting accurate readings through its software application. IPO Date: December 1, 2013 Sector: Healthcare Industry: Medical Devices Market Cap: $1.04B Activated in VL: True Average Daily Range Avg Daily Range: $0.95 | 2.78% Avg Daily Range (30 D): $0.46 | 3.45% Avg Daily Range (90 D): $0.41 | 2.91% Institutional Daily Volume Avg Daily Volume: .93M Avg Daily Volume (30 D): 1.58M Avg Daily Volume (90 D): 1.7M Trade Size Avg Trade Size (Sh.): 85 Avg Trade Size (Sh.) (30 D): 72 Avg Trade Size (Sh.) (90 D): 70 Institutional Trades Total Inst.Trades: 6,699 Avg Inst. Trade: $2.76M Avg Inst. Trade (30 D): $2.27M Avg Inst. Trade (90 D): $2.34M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $4.89M Avg Closing Trade (30 D): $3.08M Avg Closing Trade (90 D): $3.48M Avg Closing Volume: 104.88K     News Oct 17, 2025 @ 9:00 PM TNDM Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm Oct 16, 2025 @ 8:23 AM TNDM Investors Have Opportunity to Join Tandem Dia... Source: Prnewswire Oct 13, 2025 @ 10:55 PM TNDM Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm Oct 9, 2025 @ 6:51 PM TNDM Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm Oct 7, 2025 @ 5:00 PM Global Insulin Delivery Devices Market is Predicte... Source: Delveinsight Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.08 $-.78 $-1.97 Diluted EPS $-3.08 $-.78 $-1.97 Revenue $ 1B $ 240.68M $ 234.42M Gross Profit $ 526.37M $ 125.86M $ 118.41M Net Income / Loss $ -205.45M $ -52.4M $ -130.56M Operating Income / Loss $ -199.36M $ -51.81M $ -120.88M Cost of Revenue $ 475.35M $ 114.82M $ 116.02M Net Cash Flow $ 16.42M $ 10.54M $ -15.66M PE Ratio     Splits Oct 10, 2017:   1:10